1
Ignis Therapeutics
CNS diseases
HBM contact: Dr Emil Bujak
Company status: private
Ignis Therapeutics is developing and commercializing in China a pipeline
of CNS-focused products including FDA-approved cenobamate and solriamfetol.
CNS diseases
HBM contact: Dr Emil Bujak
Company status: private
Ignis Therapeutics is developing and commercializing in China a pipeline
of CNS-focused products including FDA-approved cenobamate and solriamfetol.